Home AI Chips Tech Defense Pharma Stocks Insurance Jobs Video People Topics Digests

LIVE · Friday, July 17, 2026

Home › Topic

#jiangsu hengrui pharmaceuticals

1 briefing

FDA Rejects Hengrui-Elevar Liver Cancer Drug for a Third Time

Jul 11, 2026, 5:30 AM

The AI Briefing The day's most important AI, chip & tech stories — one email each morning. Free.

AI Catalog — automated curation of AI, chips & tech news. Briefs are AI-written syntheses of the linked sources. Newsletter · RSS · llms.txt

We use cookies to understand how the site is used. Analytics stay off until you accept.